When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study (Q33459789)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

Jordan W Smoller

3

object named as

Jordan W Smoller

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1

object named as

Roy H Perlis

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

Amanda Patrick

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Philip S Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

3 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

2227-2236

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

US norms for six generic health-related quality-of-life indexes from the National Health Measurement study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Decision analysis and Markov modeling in urology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Cytochrome P450 genotyping and antidepressants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Pharmacogenetic testing in the clinical management of schizophrenia: a decision-analytic model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

The International HapMap Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Health economic evaluations: the special case of end-stage renal disease treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Managed care, access to mental health specialists, and outcomes among primary care patients with depressive symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

A survey of prescribing practices in the treatment of depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Augmentation and combination strategies in treatment-resistant depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Beyond the Tower of Babel: a nomenclature for suicidology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Methods for assessing relative importance in preference based outcome measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312011

14 July 2018

Development and testing of a utility measure for major, unipolar depression (McSad).

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.50

21 January 2018

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.50

21 January 2018

Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.50

21 January 2018

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.50

21 January 2018

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.50

21 January 2018

Utility scores of symptom profiles in major depression.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.50

21 January 2018

Pooling pharmacogenetic studies on the serotonin transporter: a mega-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.50

21 January 2018

Suicide risk during antidepressant treatment.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.50

21 January 2018

Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.50

21 January 2018

A family study of early-onset bipolar I disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.50

21 January 2018

The cost-utility of screening for depression in primary care

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.50

21 January 2018

Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications

1 reference

https://pubmed.ncbi.nlm.nih.gov/19494805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A national catalog of preference-based scores for chronic conditions in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/19494805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19494805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The costs and benefits of enhanced depression care to employers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19494805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of quality improvement programs for patients with subthreshold depression or depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19494805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19494805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modelling the cost effectiveness of antidepressant treatment in primary care

1 reference

https://pubmed.ncbi.nlm.nih.gov/19494805

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NPP.2009.50

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33459789&oldid=2195384356"